Prelude Capital Management’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$108K Buy
2025
Q1
Sell
2024
Q4
$120K Sell
2024
Q3
$167K Buy
2024
Q2
$104K Sell
2024
Q1
$144K Sell
2023
Q4
$173K Buy
2023
Q3
$121K Buy
2022
Q2
Sell
2022
Q1
$223K Buy
2020
Q4
Sell
2020
Q3
$53K Sell
2020
Q2
$131K Buy